RxDoctor Payments Data

Lav Kapadia, MD

Otolaryngology · Frisco, TXNPI 1437153418

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.3% of the total across 71 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by Stryker at 25.8% of the total.

$2,681in general payments, 2019–2025

Across 71 payments — averaging $37.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$691
  • Acclarent, Inc$459
  • Medtronic$336
  • Inspire Medical Systems, Inc.$205
  • Aerin Medical Inc.$151
  • Integra Lifesciences Corporation$101
  • plus $737 from 17 others
$151,814in research payments, 2019–2025

Across 5 payments — averaging $30,363 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Aerin Medical Inc.$152K

What the payments were for

  • Food & beverage$2,58296%
  • Education$994%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,681 in reported general payments places this provider in the 60th percentile of 729 otolaryngology providers in Texas.

See all otolaryngology providers in Texas

Medicare billing

Part B allowed, 2024
$308,188
Medicare patients
549
Services billed
3,011

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide511$12,245
Prednisolone32$3,309
Ofloxacin82$1,666
Fluocinolone Acetonide Oil27$1,262
Omeprazole62$1,239
Cefdinir54$1,211
Mupirocin153$1,104
Budesonide14$837
Azithromycin34$404
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen26$381
Ondansetron OdtOndansetron38$343
Fluticasone Propionate30$321
Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid18$201
Methylprednisolone28$168
Prednisone77$140

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Frisco

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →